Name | Type | Posted | Actions |
|---|---|---|---|
https://www.neco.navy.mil/biz_ops/840-v5soln.aspx?soln=N0018924RZ0140002 | LINK | Sep 5, 2024 | |
https://www.neco.navy.mil/biz_ops/840-v5soln.aspx?soln=N0018924RZ0140001 | LINK | Sep 5, 2024 | |
N0018924RZ0140002.pdf | Mar 14, 2024 | ||
2.06a - N0018924RZ0140001.pdf | Mar 6, 2024 | ||
PAST_PERFORMANCE_INFORMATION_FORM.docx | DOCX | Feb 13, 2024 | |
N0018924RZ014.pdf | Feb 13, 2024 |
Operational Infection Disease R&D IDIQ
Contact and place of performance
Telephone: 215-697-9674
Not specified
This acquisition will involve comprehensive scientific research and development services over the full period of performance. The required acquisition may involve, but will not be limited to: developing, refining, and executing the full spectrum of data-related tasking; examining the impact of case management services and source of delivered health care services on health care costs, patient outcomes, and health care system efficiencies; and more.
The Fleet and Industrial Supply Center, under the agency Clerk Temporary Emergency, issued solicitation N0018924RZ014 for an Indefinite Delivery Indefinite Quantity (IDIQ) contract to provide operational infectious disease research and development services. This requirement falls under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN42 for Health R&D Services; Health Care - Other; Applied Research. The comprehensive scientific services include developing and executing data-related tasking and examining the impact of case management and healthcare delivery sources on costs, patient outcomes, and system efficiencies.
The solicitation was published on February 13, 2024, with a response deadline of March 25, 2024. The acquisition documentation consists of four attachments, including the primary solicitation document and subsequent amendments. Inquiries regarding this federal opportunity are directed to the Point of Contact at 215-697-9674. This acquisition is categorized as a full-period-of-performance effort with research and development tasking across the health care and physical sciences sectors.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.